CAV-2 Vector Development and Gene Transfer in the Central and Peripheral Nervous Systems

Area of Science:

• Neuroscience
• Gene Therapy
• Molecular Biology

Background:

• Genetic modification of central nervous system (CNS) cells has advanced significantly.
• Viral and nonviral vectors are key tools for delivering genetic material to neural structures.
• These vectors enable gene replacement, pathway modification, and optogenetic control of neuronal activity.

Purpose of the Study:

• To review the application of canine adenovirus type 2 (CAV-2) vectors for gene transfer in the CNS.
• To discuss the advantages and mechanisms of CAV-2 vector use in neuronal gene therapy.

Main Methods:

• Focus on canine adenovirus type 2 (CAV-2) vectors for gene transfer.
• Discussion of vector production advancements.
• Analysis of neuronal tropism and axonal transport mechanisms.

Main Results:

• CAV-2 vectors show preferential transduction of neurons.
• Retrograde axonal transport facilitates widespread distribution within the nervous system.
• CAV-2 vectors have demonstrated utility in structure/function studies and therapeutic applications.

Conclusions:

• CAV-2 vectors are a promising tool for genetic manipulation of the CNS.
• Their properties support diverse applications in neuroscience research and potential therapies.